| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anterior rectal wall gastrointestinal stromal tumor presenting clinically as prostatic mass
|
Madden, John F.
|
|
2005
|
23 |
4 |
p. 268-272
5 p.
|
artikel
|
| 2 |
An update on randomized clinical trials in localized and locoregional prostate cancer
|
Penson, David F.
|
|
2005
|
23 |
4 |
p. 280-288
9 p.
|
artikel
|
| 3 |
A prognostic index (bladder prognostic index) for bilharzial-related invasive bladder cancer
|
Khaled, Hussein
|
|
2005
|
23 |
4 |
p. 254-260
7 p.
|
artikel
|
| 4 |
A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy
|
Ritter, Mark P.
|
|
2005
|
23 |
4 |
p. 305-
1 p.
|
artikel
|
| 5 |
Associations between polymorphisms in the steroid 5-α reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer☆
|
Salam, Muhammad T.
|
|
2005
|
23 |
4 |
p. 246-253
8 p.
|
artikel
|
| 6 |
Bladder cancer clinical trials
|
Lerner, Seth P.
|
|
2005
|
23 |
4 |
p. 275-279
5 p.
|
artikel
|
| 7 |
Contemporary clinical trials in urologic oncology
|
Stein, John P.
|
|
2005
|
23 |
4 |
p. 273-274
2 p.
|
artikel
|
| 8 |
Contents
|
|
|
2005
|
23 |
4 |
p. v-vi
nvt p.
|
artikel
|
| 9 |
Current clinical trials in renal cell carcinoma
|
Sokoloff, Mitchell H.
|
|
2005
|
23 |
4 |
p. 289-292
4 p.
|
artikel
|
| 10 |
Editorial board
|
|
|
2005
|
23 |
4 |
p. ii-
1 p.
|
artikel
|
| 11 |
Editorial board
|
|
|
2005
|
23 |
4 |
p. 303-
1 p.
|
artikel
|
| 12 |
Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: Report of a case, review of the literature, and analysis of chemokine receptor expression
|
Heresi, Gustavo A.
|
|
2005
|
23 |
4 |
p. 261-267
7 p.
|
artikel
|
| 13 |
Germ cell tumors: An update of recent data and review of active protocols in stage I and metastatic disease
|
Hahn, Noah M.
|
|
2005
|
23 |
4 |
p. 293-302
10 p.
|
artikel
|
| 14 |
Glutathione S-transferase M1 gene but not insulin-like growth factor-2 gene or epidermal growth factor gene is associated with prostate cancer☆
|
Lai, Ming-Tsung
|
|
2005
|
23 |
4 |
p. 225-229
5 p.
|
artikel
|
| 15 |
Information for Authors
|
|
|
2005
|
23 |
4 |
p. CO3-
1 p.
|
artikel
|
| 16 |
Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients
|
Zelefsky, Michael
|
|
2005
|
23 |
4 |
p. 306-307
2 p.
|
artikel
|
| 17 |
Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE
|
Ritter, Mark P.
|
|
2005
|
23 |
4 |
p. 305-306
2 p.
|
artikel
|
| 18 |
Masthead
|
|
|
2005
|
23 |
4 |
p. iii-
1 p.
|
artikel
|
| 19 |
Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy
|
Tsai, Henry K.
|
|
2005
|
23 |
4 |
p. 230-237
8 p.
|
artikel
|
| 20 |
Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy
|
Ritter, Mark P.
|
|
2005
|
23 |
4 |
p. 304-
1 p.
|
artikel
|
| 21 |
PSA failure and the risk of death in prostate cancer patients treated with radiotherapy
|
Zelefsky, Michael
|
|
2005
|
23 |
4 |
p. 308-
1 p.
|
artikel
|
| 22 |
Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer
|
Zelefsky, Michael
|
|
2005
|
23 |
4 |
p. 308-309
2 p.
|
artikel
|
| 23 |
Relative importance of PSA in prostate cancer treatment
|
Unger, Henry A.
|
|
2005
|
23 |
4 |
p. 238-245
8 p.
|
artikel
|
| 24 |
The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity
|
Zelefsky, Michael
|
|
2005
|
23 |
4 |
p. 307-
1 p.
|
artikel
|
| 25 |
Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer
|
Zelefsky, Michael
|
|
2005
|
23 |
4 |
p. 310-
1 p.
|
artikel
|
| 26 |
Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI
|
Zelefsky, Michael
|
|
2005
|
23 |
4 |
p. 309-
1 p.
|
artikel
|
Tijdschrift beschrijving